Advertisement
Advertisement
KPTI
Karyopharm Therapeutics Inc.
2.10
USDSponsored
+0.14
+7.14%
Aug 11, 15:59 UTC -4
Closed
After-Market
2.08
-0.02
-0.71%
KPTI Earnings Reports
Positive Surprise Ratio
KPTI beat 25 of 42 last estimates.
60%
Next Report
Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$33.58M
/-$0.96
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q3 25 (Revenue/ EPS)
-23.75%
/-74.87%
Karyopharm Therapeutics Inc. earnings per share and revenue
On Aug 10, 2026, KPTI reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -1.30 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 32.83 million, with a --% difference.
Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.96 USD, with revenue projected to reach 33.58 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Actinium Pharmaceuticals, Inc
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.22
Actual
$0.89
Surprise
+502.71%
Kiora Pharmaceuticals, Inc. Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.63
Actual
-$0.34
Surprise
+46.24%
AIM ImmunoTech Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.17
Actual
-$0.43
Surprise
-150.44%
Oruka Therapeutics, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.52
Actual
-$0.55
Surprise
-4.62%
Harrow, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.18
Actual
-$0.34
Surprise
-85.19%
Silence Therapeutics Plc - ADR
Report Date
Aug 10, 2026 For Q2 26
Estimate
-Actual
-$0.26
Surprise
-
Aquestive Therapeutics, Inc. Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.18
Surprise
-70.78%
Minerva Neurosciences, Inc
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.17
Surprise
-44.93%
Tonix Pharmaceuticals Holding Corp.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$2.75
Actual
-$2.44
Surprise
+11.29%
Fractyl Health, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.12
Surprise
+12.85%
FAQ
What were Karyopharm Therapeutics Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Karyopharm Therapeutics Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Karyopharm Therapeutics Inc.'s Q2 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Karyopharm Therapeutics Inc. expected to report next?
The next earning report is scheduled for Nov 02, 2026.
What are the forecasts for Karyopharm Therapeutics Inc.'s next earnings report?
Based on 5
analysts, Karyopharm Therapeutics Inc. is expected to report EPS of -$0.96 and revenue of $33.58M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement